OpenLB
Open Library of Bioscience
Advanced Search
Journal of the Egyptian National Cancer Institute
Oct 04, 2021;33 (1): 28.

Impact of different treatment plans on EQD for intracavitary brachytherapy of cervical cancer.

Osman Vefa Gul, Gokcen Inan, Hamit Basaran
Author Information
  1. Osman Vefa Gul: Department of Radiation Oncology, Faculty of Medicine, Selcuk University, Konya, Turkey. vefagul@selcuk.edu.tr. ORCID
  2. Gokcen Inan: Department of Radiation Oncology, Faculty of Medicine, Selcuk University, Konya, Turkey.
  3. Hamit Basaran: Department of Radiation Oncology, Faculty of Medicine, Selcuk University, Konya, Turkey.
PMID: 34604928 DOI: 10.1186/s43046-021-00084-2

Abstract

BACKGROUND: Cancer is one of the leading causes of death worldwide. According to GLOBOCAN estimates, there were 341,831 deaths from cervical cancer in 185 countries in 2020. The aim of this study was to compare equieffective dose (EQD) at 2 Gy per fraction by using dose volume histograms (DVHs) derived from external beam radiotherapy (EBRT) and high-dose rate brachytherapy (HDR-BRT) treatment plans used in cervical cancer radiotherapy.
METHODS: Fifteen patients with stage IIB-IIIB cervical cancer were included in this retrospective study. Treatment with three-dimensional conformal radiotherapy (3D-CRT) or intensity-modulated radiotherapy (IMRT) was planned for all patients in 28 fractions, with a total of 50.4 Gy to be delivered to the whole pelvic region. After EBRT, manual optimization (MO) or inverse optimization (IO) HDR-BRT plans were created in 4 fractions with a total of 28 Gy. The plans obtained were grouped as IMRT + IO, IMRT + MO, 3DCRT + IO, and 3DCRT + MO by calculating EQDs among these plans. D, D, and D values were compared in all plans for CTV total EQD. In addition, EQD values ​for critical organs at risk (OARs) such as rectum, bladder, small intestine, and sigmoid were compared in all plans for volumes of 2 cm, 1 cm, and 0.1 cm, respectively.
RESULTS: There was no significant difference between the treatment groups in terms of CTV D and CTV D values; However, CTV D (p = 0.000) and CTVHR D98 (p = 0.000) values ​were found to be better in IMRT + IO technique. The IMRT + IO technique provided better protection for 2 cm, 1 cm, and 0.1 cm volumes of OARs compared to other techniques.
CONCLUSIONS: Considering all parameters such as CTV, CTV, rectum, bladder, small intestine, and sigmoid, combination of IMRT + IO treatment option was found to be significantly superior in total EQD2 calculations compared to other plans.

Keywords

Brachytherapy Cervical cancer EQD2

References

  1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660 . [DOI: 10.3322/caac.21660]
  2. Nag S, Erickson B, Thomadsen B, Orton C, Demanes JD, Petereit D. The American Brachytherapy society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2000;48(1):201–11. https://doi.org/10.1016/S0360-3016(00)00497-1 . [DOI: 10.1016/S0360-3016(00)00497-1]
  3. Duan J, Kim RY, Elassal S, Lin HY, Shen S. Conventional high-doserate brachytherapy with concomitant complementary IMRT boost: a novel approach for improving cervical tumor dose coverage. Int J Radiat Oncol Biol Phys. 2008;71(3):765–71. https://doi.org/10.1016/j.ijrobp.2007.10.064 . [DOI: 10.1016/j.ijrobp.2007.10.064]
  4. Assenholt MS, Petersen JB, Nielsen SK, Lindegaard JC, Tanderup K. K. A dose planning study on applicator guided stereotactic IMRT boost in combination with 3D MRI based brachytherapy in locally advanced cervical cancer. Acta Oncol. 2008;47(7):1337–43. https://doi.org/10.1080/02841860802266698 . [DOI: 10.1080/02841860802266698]
  5. Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, et al. Concur- rentcisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340:1144–53. [DOI: 10.1056/NEJM199904153401502]
  6. Kravets OA, Kozlov OV, Fedyanina AA, et al. Methodical aspects of contact radiation therapy of cervical cancer using 3D-planning. Med Phys. 2017;73(1):16–24.
  7. Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol. 2004;22(5):872–80. https://doi.org/10.1200/JCO.2004.07.197 . [DOI: 10.1200/JCO.2004.07.197]
  8. Potter R, Kirisits C, Erickson C, et al. Prescribing, recording, and reporting brachytherapy for cancer of the cervix. J ICRU. 2013;13:NP.
  9. Potter R, Haei-Meder C, Limbergen EV, et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol. 2006;78(1):67–77. https://doi.org/10.1016/j.radonc.2005.11.014 . [DOI: 10.1016/j.radonc.2005.11.014]
  10. Latest Global Cancer Data – World Health Organization Press release No 263, 12 September 2018.
  11. International Commission on Radiation Units and Measurements Report. Prescribing, recording, and reporting brachytherapy for cancer of the cervix (ICRU report 89), Bedhesda 2013.
  12. Viswanathan AN, Beriwal S, de los Santos JF, et al. American brachytherapy society consensus guidelines locally advanced carcinoma of the cervix. Part II: High dose rate brachytherapy. Brachytherapy. 2012;11(1):47–52. https://doi.org/10.1016/j.brachy.2011.07.002 . [DOI: 10.1016/j.brachy.2011.07.002]
  13. Potter R, Tanderup K, Kirisits C, et al. The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies. Clin Transl Radiat Oncol. 2018;9:48–60. https://doi.org/10.1016/j.ctro.2018.01.001 . [DOI: 10.1016/j.ctro.2018.01.001]
  14. Anbumani S, Anchineyan P, Narayanasamy A, Palled SR, Sathisan S, Jayaraman P, et al. Treatment planning methods in high dose rate interstitial brachytherapy of carcinoma cervix: a dosimetric and radiobiological analysis. ISRN Oncol. 2014;2014:125020. [PMID: 24587919]
  15. Lim K, Small W Jr, Portelance L, Creutzberg C, Jurgenliemk-Schulz IM, Mundt A, et al. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer. Int J Radiat Oncol Biol Phys. 2011;79(2):348–55. https://doi.org/10.1016/j.ijrobp.2009.10.075 . [DOI: 10.1016/j.ijrobp.2009.10.075]
  16. Dimopoulos JC, Lang S, Kirisits C, et al. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys. 2009;75(1):56–63. https://doi.org/10.1016/j.ijrobp.2008.10.033 . [DOI: 10.1016/j.ijrobp.2008.10.033]
  17. Jamema SV, Kirisits C, Mahantshetty U, Trnkova P, Deshpande DD. Comparison of DVH parameters and loading patterns of standard loading, manual and inverse optimization for intracavitary brachytherapy on a subset of tandem/ovoid cases. Radiother Oncol. 2010;97(3):501–6. https://doi.org/10.1016/j.radonc.2010.08.011 . [DOI: 10.1016/j.radonc.2010.08.011]
  18. Kumar M, Thangaraj R, Alva R, Koushik K, Ponni A, Achar J. Impact of different dose prescription schedules on EQD2 in high-dose-rate intracavitary brachytherapy of carcinoma cervix. J Contemp Brachyther. 2019;11(2):189–93. https://doi.org/10.5114/jcb.2019.84586 . [DOI: 10.5114/jcb.2019.84586]
  19. Potter R, Georg P, Dimopoulos JC, et al. Clinical outcome of protocol-based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical can-cer. Radiother Oncol. 2011;100(1):116–23. https://doi.org/10.1016/j.radonc.2011.07.012 . [DOI: 10.1016/j.radonc.2011.07.012]

MeSH Term

Brachytherapy
Female
Humans
Radiotherapy, Conformal
Radiotherapy, Intensity-Modulated
Retrospective Studies
Uterine Cervical Neoplasms
Journal Article
Article has an altmetric score of 1

Word Cloud

Created with Highcharts 10.0.0plans+IMRTIODCTVcmcancercervicalEQDradiotherapytreatmenttotalvaluescompared102GyMOstudydoseEBRTbrachytherapyHDR-BRTpatients28fractions4optimization3DCRTOARsrectumbladdersmallintestinesigmoidvolumesp=000foundbettertechniqueEQD2BACKGROUND:CanceroneleadingcausesdeathworldwideAccordingGLOBOCANestimates341831deaths185countries2020aimcompareequieffectiveperfractionusingvolumehistogramsDVHsderivedexternalbeamhigh-doserateusedMETHODS:FifteenstageIIB-IIIBincludedretrospectiveTreatmentthree-dimensionalconformal3D-CRTintensity-modulatedplanned50deliveredwholepelvicregionmanualinversecreatedobtainedgroupedcalculatingEQDsamongaddition​forcriticalorgansriskrespectivelyRESULTS:significantdifferencegroupstermsHoweverCTVHRD98​wereprovidedprotectiontechniquesCONCLUSIONS:ConsideringparameterscombinationoptionsignificantlysuperiorcalculationsImpactdifferentintracavitaryBrachytherapyCervical

Similar Articles

Cited By